இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம் Today - Breaking & Trending Today

A call to action for made-in-India APIs - The Hindu BusinessLine

A call to action for made-in-India APIs - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Prasanta Kumar Ghosh , Satish Mehta , Mahesh Doshi , Yasir Rawjee , Glenmark Life Sciences , Emcure Pharmaceuticals , Chief Executive Officer , Laboratories Co Chairman , National President , Indian Drug Manufacturers Association , Information System , Developing Countries , Product Linked Incentive , சத்தீஷ் மேத்தா , மகேஷ் தோஷி , க்ளேண்மர்க் வாழ்க்கை அறிவியல் , தலைமை நிர்வாகி அதிகாரி , ஆய்வகங்கள் இணை தலைவர் , தேசிய ப்ரெஸிடெஂட் , இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம் , தகவல் அமைப்பு , வளரும் நாடுகள் , ப்ராடக்ட் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை ,

Container shortage: Shipping costs sky rocket for Chennai port customers | Hellenic Shipping News Worldwide

Container shortage: Shipping costs sky rocket for Chennai port customers | Hellenic Shipping News Worldwide
hellenicshippingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hellenicshippingnews.com Daily Mail and Mail on Sunday newspapers.

United States , Tamil Nadu , Israr Ahmed , Sajin Verghese , Indian Drug Manufacturers Association , Bumilaut Shipping Services , Federation Of Indian Exporters Organisation Israr Ahmed , Ennore Ports Steamer Agents Association , Chennai Port , Indian Exporters Organisation Israr Ahmed , Drug Manufacturers Association , Puducherry State Boardj Jayaseelan , ஒன்றுபட்டது மாநிலங்களில் , தமிழ் நாடு , இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம் , சென்னை போர்த் , மருந்து உற்பத்தியாளர்கள் சங்கம் ,

Drugmakers cry 'monopoly' as Modi govt picks 1 firm each to make over 20 key raw materials

Drugmakers cry ‘monopoly’ as Modi govt picks 1 firm each to make over 20 key raw materials
Himani Chandna
© Provided by The Print
New Delhi: India’s weapon to fight its dependence on Chinese medicine imports the Production-Linked Incentive scheme may end up creating a monopoly of just a few drugmakers, and the pharma lobby has expressed its concern about this to the Narendra Modi government.
The PLI scheme launched by the government in July provides monetary incentives to increase the production of 41 critical raw materials, including active pharmaceutical ingredients (APIs), intermediates and key starting materials, distributed in four categories, that are required for manufacturing final formulations (medicines) in India. ....

New Delhi , Sun Pharma , Narendra Modi , Aurobindo Pharma , Mansukh Mandaviya , Mahesh Doshi , Shreyas Sharma , Torrent Pharmaceuticals , Centrient Pharmaceuticals , Ministry Of Chemicals , Jubilant Life Sciences , Department Of Pharmaceuticals Do , Department Of Pharmaceuticals , Indian Drug Manufacturers Association , Production Linked Incentive , Telangana Based Honour Labs , Jubilant Life , Fertilisers Minister Mansukh Mandaviya , Netherlands Based Centrient Pharmaceuticals , Natural Biogenex , Hyderabad Based Aurobindo Pharma , Karnataka Antibiotics , Aminocephalosporanic Acid , Erythromycin Thiocyanate , புதியது டெல்ஹி , சூரியன் பார்மா ,

Remdesivir output up, but supply bottlenecks remain - The Hindu BusinessLine

Remdesivir output up, but supply bottlenecks remain
×
The production of most sought after anti-viral drug, Remdesivir, has increased significantly but its availability continues to be a challenge in some States and private hospitals.
The production capacity of the remdesivir injection by seven domestic manufacturers has increased from 38 lakh vials per month to nearly 119 lakh vials, the Ministry of Chemicals and Fertilisers said on Monday.
Developed by US-based Gilead Sciences Inc, Remdesivir is being used to treat Covid-19 patients with oxygen saturation below 95 per cent and those with moderate to severe symptoms. Hyderabad-based Hetero Drugs is a major manufacturer of Remdisivir followed by Cipla, Zydus Cadila, Mylan Labs, Dr Reddy’s Labs, Syngene and Jubilant Ingrevia. ....

Andhra Pradesh , Tamil Nadu , S Ravi Shankar Narayan , Zydus Cadila , Maheshh Doshi , Indian Drug Manufacturers Association , Dr Reddy Labs , Ministry Of Chemicals , Gilead Sciences Inc , Drug Control Administration , Hetero Drugs , Mylan Labs , Ravi Shankar Narayan , Telangana Government , National President , Supply Bottlenecks , ஆந்திரா பிரதேஷ் , தமிழ் நாடு , கள் ரவி ஷங்கர் நாராயண் , ஜய்துச் காடிலா , இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம் , டாக்டர் சிவப்பு ஆய்வகங்கள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் , கிலியட் அறிவியல் இன்க் , ஹெடரொ மருந்துகள் , மைலன் ஆய்வகங்கள் ,

India's covid collapse, part 6: The boom in black market for live-saving drugs

UPDATED: May 12, 2021 09:24 IST
LIFELINE: A Chennai resident with Remdesivir purchased from a government facility (Arun Sankar/Getty Images)
When a harried Naresh Indulkar, a resident of Mumbai’s Thane, went searching for three vials of Remdesivir for a relative in critical condition in hospital, it took nearly six hours to find a pharmacy with stock. “Rs 22,000 a vial,” whispered the man behind the counter, though the marked retail price was only Rs 1,800. Distraught, Indulkar returned to his apartment. A glimmer of hope appeared in the form of a reply from his neighbour to an appeal he had posted on his residential society’s WhatsApp group. On calling him, the neighbour came up two floors and offered Indulkar three spare vials of Remdesivir he had. “He had bought eight vials at a premium to treat his father,” recalls Indulkar. “Five sufficed, and as thanksgiving, he offered me the rest at the marked price, unmindful of his financial loss.” ....

Madhya Pradesh , Andhra Pradesh , Uttar Pradesh , United States , Zydus Cadila , Mansukh Mandaviya , Daarab Patel , Teva Pharma , Naresh Indulkar , Sanjay Bhatnagar , Majid Sabir , Saurabh Sonkar , Kumar Mishra , Rajasthan Medical Services Corporation , Lucknow Medical Association , Rajasthan High Court , Supreme Court , Indian Drug Manufacturers Association , Dr Reddy Labs , National Pharmaceutical Pricing Authority On , Gilead Sciences United States , Gandhi Medical College , Gilead Life Sciences , Life Sciences , Hetero Drugs , Mylan Labs ,